Notes
One of the researchers received funding from Pfizer, with which several of the researchers were affiliated.
Reference
Ellis JJ, et al. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. ClinicoEconomics and Outcomes Research : 17 Oct 2014. Available from: URL: http://dx.doi.org/10.2147/CEOR.S66759
Rights and permissions
About this article
Cite this article
Drug interactions more common and costly for duloxetine. PharmacoEcon Outcomes News 714, 19 (2014). https://doi.org/10.1007/s40274-014-1640-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1640-2